Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DocGo (DCGO) EBIT (2020 - 2025)

DocGo has reported EBIT over the past 6 years, most recently at -$104.6 million for Q4 2025.

  • Quarterly results put EBIT at -$104.6 million for Q4 2025, down 1299.4% from a year ago — trailing twelve months through Dec 2025 was -$178.0 million (down 720.57% YoY), and the annual figure for FY2025 was -$178.0 million, down 720.57%.
  • EBIT for Q4 2025 was -$104.6 million at DocGo, down from -$42.0 million in the prior quarter.
  • Over the last five years, EBIT for DCGO hit a ceiling of $15.9 million in Q1 2024 and a floor of -$104.6 million in Q4 2025.
  • Median EBIT over the past 5 years was $1.5 million (2021), compared with a mean of -$4.9 million.
  • Biggest five-year swings in EBIT: soared 73669.88% in 2021 and later plummeted 1299.4% in 2025.
  • DocGo's EBIT stood at $15.5 million in 2021, then plummeted by 99.48% to $80116.0 in 2022, then soared by 14470.94% to $11.7 million in 2023, then tumbled by 164.02% to -$7.5 million in 2024, then plummeted by 1299.4% to -$104.6 million in 2025.
  • The last three reported values for EBIT were -$104.6 million (Q4 2025), -$42.0 million (Q3 2025), and -$17.5 million (Q2 2025) per Business Quant data.